B. Riley raised the firm’s price target on Zymeworks (ZYME) to $40 from $30 and keeps a Buy rating on the shares. Zymeworks’ shift to a royalty-aggregation strategy aims to optimize future de-risked ...

APT24 and Autumn Dragon launch multi-year espionage campaigns using BADAUDIO, supply chain attacks, and new CVE-2025-8088 ...

The Cyprus Securities and Exchange Commission (CySEC) said the listed websites — including fernrise.com, market-trading.ltd, ...

Corporate representation at COP30 has sharply declined since the 2021 Glasgow summit, replacing high-profile marketing stunts ...

A loud boom has been heard throughout Jefferson County over the last couple of months. Those who have heard it say it usually ...

The China-aligned advanced persistent threat (APT) tracked as 'PlushDaemon' is hijacking software update traffic to deliver ...

The global geothermal power market is projected to reach $14.5 billion by 2034, driven by its high-capacity baseload power, ...

Quantum computers, which operate leveraging effects rooted in quantum mechanics, have the potential of tackling some ...

Utah's Minor Protection in Social Media Act requires social media platforms to take extra care with minor users. But a ...

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

Nicholas Crypto Income ETF offers a unique blend of cryptocurrency, crypto miners, trading platforms, and semiconductor ...